Tune Therapeutics is a biotechnology innovator advancing a new class of epi-therapeutic medicines using its proprietary TEMPO epigenomic control platform. Rather than editing DNA sequences, Tune’s technology precisely tunes gene activity up or down to restore healthy cellular function, offering the potential to treat complex, common, and chronic diseases that have been difficult to address with traditional genetic medicine.

VISIT WEBSITE